G Medical Innovations Holdings Ltd. (GMVD): Price and Financial Metrics
GET POWR RATINGS... FREE!
GMVD Stock Price Chart Interactive Chart >
GMVD Price/Volume Stats
|Current price||$0.70||52-week high||$6.74|
|Prev. close||$0.66||52-week low||$0.60|
|Day high||$0.70||Avg. volume||1,383,630|
|50-day MA||$1.15||Dividend yield||N/A|
|200-day MA||$2.23||Market Cap||N/A|
G Medical Innovations Holdings Ltd. (GMVD) Company Bio
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days. It also develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. G Medical Innovations Holdings Ltd was founded in 2014 and is based in Rehovot, Israel.
Most Popular Stories View All
GMVD Latest News Stream
|Loading, please wait...|
GMVD Latest Social Stream
View Full GMVD Social Stream
Latest GMVD News From Around the Web
Below are the latest news stories about G Medical Innovations Holdings Ltd that investors may wish to consider to help them evaluate GMVD as an investment opportunity.
G Medical Innovations Announces that More than 200,000 LiveNow At-Home COVID-19 PCR Tests are Now Available at 4,000+ Circle K Locations Nationally, with 300,000 More to Ship in the Coming Weeks
PCR collection kit tests provide 24–48-hour certified lab results and retail for $9.99
G Medical Innovations (NASDAQ:GMVD) continues to trade lower in the pre-market with a decline of ~2% following a selloff of more than 20% last Friday in reaction to the company’s announcement over a securities purchase agreement with Lind Global Fund II LP. Early this month, the company had disclosed a definitive securities purchase agreement...
G Medical Innovations (NASDAQ: GMVD) to Open One of the Largest COVID-19 Test Processing Labs and Walk-in Testing Facilities in the U.S.
The 26,000 sq ft site in Laguna, CA opens next week and will be able to process approximately 100,000 tests daily
G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) (the "Company"), a telehealth, medical device, and remote patient monitoring company providing clinical-grade solutions for consumers, medical prof...
G Medical Innovations Joins Forces with Serology Covid Testing to Support Safer Classroom Learning in California School Districts Amid Omicron Variant Surge
On average, G Medical expects to collect an average of $197.88 per patient encounter, which could amount to more than $1,000,000 in gross revenue per week
GMVD Price Returns